Health tax issues and trade, Issues related to Small Business Innovation Research Program. PAHPA Reauthorization
Health tax issues and trade
Issues related to health data privacy.
Issues related to CHIPS implementation.
H.R. 1691; Ensuring Patient Access to Critical Breakthrough Products Act of 2023
Issues related to transitional coverage of emerging technologies
Duration: September 1, 2021
to
present
General Issues: Medical/Disease Research/Clinical Labs , Taxation/Internal Revenue Code , Computer Industry , Trade (Domestic & Foreign) , Medicare/Medicaid
Spending: about $365,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2021: U.S. Senate, House of Representatives
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Hadley Sosnoff Legislative Director, ID-1; Legislative Assistant ID-1; Legislative Correspondent NY-18
Legislative Director (ID-1), Legislative Assistant (ID-1), Legislative Correspondent (NY-18), Staff Assistant (NY-18)
Legislative Director, ID-1; Legislative Assistant ID-1; Legislative Correspondent NY-18, Staff Assistant NY-18
Legislative Director, ID-1; Legislative Assistant, ID-1; Legislative Correspondent, NY-18; Staff Assistant NY-18
Scott Eckart n/a
Michael Claunch n/a
Leigh Parker Pross n/a
Meghan O'Hara n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, EMERGENT STRATEGIES lobbied for AdvaMed:Advanced Medical Technology Association , earning $45,000. The report was filed on April 2.
Original Filing: 301546015.xml
Lobbying Issues
Health tax issues and trade, Issues related to Small Business Innovation Research Program. PAHPA Reauthorization
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Health tax issues and trade
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to health data privacy.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to CHIPS implementation.
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
H.R. 1691; Ensuring Patient Access to Critical Breakthrough Products Act of 2023
Issues related to transitional coverage of emerging technologies
Agencies Lobbied
U.S. Senate
4th Quarter, 2023
In Q4, EMERGENT STRATEGIES lobbied for AdvaMed:Advanced Medical Technology Association , earning $45,000. The report was filed on Jan. 19.
Original Filing: 301531547.xml
Lobbying Issues
Health tax issues and trade, Issues related to Small Business Innovation Research Program. PAHPA Reauthorization
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Health tax issues and trade
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to health data privacy.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to CHIPS implementation.
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
H.R. 1691; Ensuring Patient Access to Critical Breakthrough Products Act of 2023
Issues related to transitional coverage of emerging technologies
Agencies Lobbied
U.S. Senate
3rd Quarter, 2023
In Q3, EMERGENT STRATEGIES lobbied for AdvaMed:Advanced Medical Technology Association , earning $45,000. The report was filed on Oct. 16, 2023.
Original Filing: 301501465.xml
Lobbying Issues
Health tax issues and trade, Issues related to Small Business Innovation Research Program. PAHPA Reauthorization
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Health tax issues and trade
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to health data privacy.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to CHIPS implementation.
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
H.R. 1691; Ensuring Patient Access to Critical Breakthrough Products Act of 2023
Issues related to transitional coverage of emerging technologies
Agencies Lobbied
U.S. Senate
2nd Quarter, 2023
In Q2, EMERGENT STRATEGIES lobbied for AdvaMed:Advanced Medical Technology Association , earning $45,000. The report was filed on July 5, 2023.
Original Filing: 301473133.xml
Lobbying Issues
Health tax issues and trade, Issues related to Small Business Innovation Research Program. PAHPA Reauthorization
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Health tax issues and trade
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues related to health data privacy.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to CHIPS implementation.
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
1st Quarter, 2023
In Q1, EMERGENT STRATEGIES lobbied for AdvaMed:Advanced Medical Technology Association , earning $45,000. The report was filed on April 17, 2023.
Original Filing: 301452605.xml
Lobbying Issues
Health tax issues and trade, Issues related to Small Business Innovation Research Program
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Health tax issues and trade,
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
issues related to data privacy.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to CHIPS implementation
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
4th Quarter, 2022
In Q4, EMERGENT STRATEGIES lobbied for AdvaMed:Advanced Medical Technology Association , earning $30,000. The report was filed on Jan. 20, 2023.
Original Filing: 301437271.xml
Lobbying Issues
Health tax issues and trade, H.R.4043 - Ensuring Patient Access to Critical Breakthrough Products Act of 2021
Issues related to Small Business Innovation Research Program
Medical Device User Fee Amendments IV
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Health tax issues and trade, H.R.4043 - Ensuring Patient Access to Critical Breakthrough Products Act of 2021
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
issues related to data privacy.
H.R. 8152 - American Data Privacy and Protection Act.
S. 3195 - Consumer Online Privacy Rights Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to semiconductor chips in S. 1260 - USICA and H.R.4521 - America COMPETES Act of 2022.
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
3rd Quarter, 2022
In Q3, EMERGENT STRATEGIES lobbied for AdvaMed:Advanced Medical Technology Association , earning $30,000. The report was filed on Oct. 20, 2022.
Original Filing: 301413309.xml
Lobbying Issues
Health tax issues and trade, H.R.4043 - Ensuring Patient Access to Critical Breakthrough Products Act of 2021
Issues related to Small Business Innovation Research Program
Medical Device User Fee Amendments IV
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Health tax issues and trade, H.R.4043 - Ensuring Patient Access to Critical Breakthrough Products Act of 2021
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
issues related to data privacy.
H.R. 8152 - American Data Privacy and Protection Act.
S. 3195 - Consumer Online Privacy Rights Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to semiconductor chips in S. 1260 - USICA and H.R.4521 - America COMPETES Act of 2022.
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
2nd Quarter, 2022
In Q2, EMERGENT STRATEGIES lobbied for AdvaMed:Advanced Medical Technology Association , earning $30,000. The report was filed on July 18, 2022.
Original Filing: 301382442.xml
Lobbying Issues
Health tax issues and trade, H.R.4043 - Ensuring Patient Access to Critical Breakthrough Products Act of 2021
Issues related to Small Business Innovation Research Program
Medical Device User Fee Amendments IV
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Health tax issues and trade, H.R.4043 - Ensuring Patient Access to Critical Breakthrough Products Act of 2021
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
issues related to data privacy.
H.R. 8152 - American Data Privacy and Protection Act.
S. 3195 - Consumer Online Privacy Rights Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to semiconductor chips in S. 1260 - USICA and H.R.4521 - America COMPETES Act of 2022
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
1st Quarter, 2022
In Q1, EMERGENT STRATEGIES lobbied for AdvaMed:Advanced Medical Technology Association , earning $20,000. The report was filed on April 20, 2022.
Original Filing: 301365413.xml
Lobbying Issues
Health tax issues and trade, H.R.4043 - Ensuring Patient Access to Critical Breakthrough Products Act of 2021
Issues related to Small Business Innovation Research Program
Medical Device User Fee Amendments IV
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Health tax issues and trade, H.R.4043 - Ensuring Patient Access to Critical Breakthrough Products Act of 2021
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
issues related to data privacy
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to semiconductor chips in S. 1260 - USICA and H.R.4521 - America COMPETES Act of 2022
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
4th Quarter, 2021
In Q4, EMERGENT STRATEGIES lobbied for AdvaMed:Advanced Medical Technology Association , earning $30,000. The report was filed on Jan. 21, 2022.
Original Filing: 301339324.xml
Lobbying Issues
Health tax issues and trade, H.R.4043 - Ensuring Patient Access to Critical Breakthrough Products Act of 2021
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs/Internal Revenue Code
Lobbying Issues
issues related to data privacy
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2021
In Q3, EMERGENT STRATEGIES lobbied for AdvaMed:Advanced Medical Technology Association . The report was filed on Nov. 23, 2021.
Original Filing: 301318529.xml
Lobbying Issues
Health tax issues and trade, H.R.4043 - Ensuring Patient Access to Critical Breakthrough Products Act of 2021
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs/Internal Revenue Code
Lobbying Issues
issues related to data privacy
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2021
Emergent Strategies filed a lobbying registration on Oct. 20, 2021 to represent AdvaMed: Advanced Medical Technology Association, effective Sept. 1, 2021.
Original Filing: 301311049.xml
Issue(s) they said they’d lobby about: Health tax issues and trade, H.R.4043 - Ensuring Patient Access to Critical Breakthrough Products Act of 2021 .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...